Cart
sales@molnova.com
Chikusetsusaponin IV
CAS No. 7518-22-1
Chikusetsusaponin IV( —— )
Catalog No. M19075 CAS No. 7518-22-1
Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 167 | In Stock |
|
| 50MG | 244 | In Stock |
|
| 100MG | 362 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameChikusetsusaponin IV
-
NoteResearch use only, not for human use.
-
Brief DescriptionChikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
-
DescriptionChikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFas/FasL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7518-22-1
-
Formula Weight927.09
-
Molecular FormulaC47H74O18
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (107.87 mM)
-
SMILESCC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(O7)CO)O)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
N6-(p-Hydroxypheneth...
N6-(p-Hydroxyphenethyl)-Adenosine) is an adenosine analogue.
-
NDMC101
NDMC101 is an inhibitor of dipeptidyl peptidase-IV activity in human T cells and exhibits immunomodulatory effects. It also acts as a novel inhibitor of NFATc1 and NF-κB activity.NDMC101 markedly inhibited RANKL-induced formation of TRAP+ multinucleated cells in RAW264.7 and bone marrow macrophage cells (BMMs).?
-
Elotuzumab
Elotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.
